Insider Trading Activity For Foundation Medicine, Inc. (NASDAQ:FMI)
Krishna Yeshwant , Director of Foundation Medicine, Inc. (NASDAQ:FMI) reportedly Sold 4,800 shares of the company’s stock at an average price of 40.01 for a total transaction amount of $192,048.00 SEC Form
Insider Trading History For Foundation Medicine, Inc. (NASDAQ:FMI)
Analyst Ratings For Foundation Medicine, Inc. (NASDAQ:FMI)
These are 2 Hold Ratings, 2 Buy Ratings .
The current consensus rating for Foundation Medicine, Inc. (NASDAQ:FMI) is Buy (Score: 2.50) with a consensus target price of $35.00 , a potential (9.56% downside)
Analyst Ratings History For Foundation Medicine, Inc. (NASDAQ:FMI)
- On 9/16/2015 Wells Fargo & Company Downgraded rating Outperform to Market Perform
- On 11/4/2015 Wedbush Lower Price Target of rating Neutral with a price target of $26.00 to $19.00
- On 2/26/2016 Goldman Sachs Group, Inc. (The) Lower Price Target of rating Neutral with a price target of $17.00 to $15.00
- On 5/4/2016 Leerink Swann Reiterated Rating Hold
- On 8/3/2016 J P Morgan Chase & Co Reiterated Rating Hold with a price target of $25.00
- On 11/3/2016 Benchmark Co. Downgraded rating Buy to Hold
- On 3/7/2017 Janney Montgomery Scott Upgraded rating Sell to Neutral with a price target of $31.00
Recent Trading Activity for Foundation Medicine, Inc. (NASDAQ:FMI)
Shares of Foundation Medicine, Inc. closed the previous trading session at 38.70 down -0.45 -1.15% with 165,183 shares trading hands.